Decoy Therapeutics Files Prospectus For Offering 3.767M Common Shares On Behalf Of Common Shareholders

Benzinga Newsdesk www.benzinga.com Neutral 93.5%

Neg 0% Neu 93.5% Pos 0%

https://www.sec.gov/Archives/edgar/data/1615219/000119312526300954/dcoy-20260710.htm

Comments

No comments yet. Be the first!